Samlowski W - Search Results

1

Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study.

Whitehead RP, Unger JM, Flaherty LE, Eckardt JR, Taylor SA, Didolkar MS, Samlowski W, Sondak VK. Whitehead RP, et al. Among authors: samlowski w. Invest New Drugs. 2001;19(3):239-43. doi: 10.1023/a:1010624702340. Invest New Drugs. 2001. PMID: 11561681 Free article. Clinical Trial.

2

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.

Whitehead RP, Moon J, McCachren SS, Hersh EM, Samlowski WE, Beck JT, Tchekmedyian NS, Sondak VK; Southwest Oncology Group. Whitehead RP, et al. Cancer. 2004 Apr 15;100(8):1699-704. doi: 10.1002/cncr.20183. Cancer. 2004. PMID: 15073859 Free article. Clinical Trial.

3

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.

Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Goodwin JW, Balcerzak SP, Samlowski WE, Lenz HJ, Macdonald JS. Whitehead RP, et al. Invest New Drugs. 2004 Aug;22(3):335-41. doi: 10.1023/B:DRUG.0000026261.76197.54. Invest New Drugs. 2004. PMID: 15122082 Clinical Trial.

4

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.

Taylor SA, Fleming T, Von Hoff DD, McCracken JD, Bukowski RM, Talley RW, Natale RB, Guy JT, Samlowski WE, Costanzi JH. Taylor SA, et al. Among authors: samlowski we. Invest New Drugs. 1990 Feb;8(1):77-80. doi: 10.1007/BF00216928. Invest New Drugs. 1990. PMID: 2188928 Free article. Clinical Trial.

5

A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).

Samlowski WE, Moon J, Tuthill RJ, Heinrich MC, Balzer-Haas NS, Merl SA, DeConti RC, Thompson JA, Witter MT, Flaherty LE, Sondak VK. Samlowski WE, et al. Am J Clin Oncol. 2010 Oct;33(5):495-9. doi: 10.1097/COC.0b013e3181b9cf04. Am J Clin Oncol. 2010. PMID: 20019577 Free PMC article. Clinical Trial.

6

Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.

Meyskens FL Jr, Liu PY, Tuthill RJ, Sondak VK, Fletcher WS, Jewell WR, Samlowski W, Balcerzak SP, Rector DJ, Noyes RD, et al. Meyskens FL Jr, et al. Among authors: samlowski w. J Clin Oncol. 1994 Oct;12(10):2060-5. doi: 10.1200/JCO.1994.12.10.2060. J Clin Oncol. 1994. PMID: 7931474 Clinical Trial.

7

High frequency of brain metastases after adjuvant therapy for high-risk melanoma.

Samlowski WE, Moon J, Witter M, Atkins MB, Kirkwood JM, Othus M, Ribas A, Sondak VK, Flaherty LE. Samlowski WE, et al. Cancer Med. 2017 Nov;6(11):2576-2585. doi: 10.1002/cam4.1223. Epub 2017 Oct 10. Cancer Med. 2017. PMID: 28994212 Free PMC article. Clinical Trial.

8

Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.

Salmon SE, Crowley JJ, Balcerzak SP, Roach RW, Taylor SA, Rivkin SE, Samlowski W. Salmon SE, et al. Among authors: samlowski w. J Clin Oncol. 1998 Mar;16(3):890-6. doi: 10.1200/JCO.1998.16.3.890. J Clin Oncol. 1998. PMID: 9508170 Clinical Trial.

9

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.

Samlowski WE, Gundacker H, Kuebler JP, Giguere JK, Mills GM, Schuller DE, Ensley JF. Samlowski WE, et al. Invest New Drugs. 2001;19(4):311-5. doi: 10.1023/a:1010657609609. Invest New Drugs. 2001. PMID: 11561690 Clinical Trial.

10

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).

Meyers FJ, Lew D, Lara PN Jr, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED. Meyers FJ, et al. Among authors: samlowski w. Invest New Drugs. 1998-1999;16(4):347-51. doi: 10.1023/a:1006128024879. Invest New Drugs. 1998. PMID: 10426670 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters